Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$4.15
-0.5%
$5.22
$1.75
$6.40
$155.74M-0.07206,399 shs102,835 shs
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
$3.25
+0.9%
$3.81
$3.14
$6.61
$149.28M0.43245,510 shs116,607 shs
Owlet, Inc. stock logo
OWLT
Owlet
$5.00
-0.6%
$5.54
$4.19
$16.94
$145.53M1.9262,181 shs113,720 shs
PAVmed Inc. stock logo
PAVM
PAVmed
$5.28
+3.7%
$5.25
$3.85
$28.44
$42.22M0.5348,348 shs66,483 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
0.00%-3.71%-31.97%-8.99%+414,999,900.00%
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
0.00%+0.62%-8.71%-17.30%-19.55%
Owlet, Inc. stock logo
OWLT
Owlet
0.00%+0.40%-8.05%+7.07%-32.47%
PAVmed Inc. stock logo
PAVM
PAVmed
0.00%+7.32%+8.98%-3.12%-62.55%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$4.15
-0.5%
$5.22
$1.75
$6.40
$155.74M-0.07206,399 shs102,835 shs
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
$3.25
+0.9%
$3.81
$3.14
$6.61
$149.28M0.43245,510 shs116,607 shs
Owlet, Inc. stock logo
OWLT
Owlet
$5.00
-0.6%
$5.54
$4.19
$16.94
$145.53M1.9262,181 shs113,720 shs
PAVmed Inc. stock logo
PAVM
PAVmed
$5.28
+3.7%
$5.25
$3.85
$28.44
$42.22M0.5348,348 shs66,483 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
0.00%-3.71%-31.97%-8.99%+414,999,900.00%
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
0.00%+0.62%-8.71%-17.30%-19.55%
Owlet, Inc. stock logo
OWLT
Owlet
0.00%+0.40%-8.05%+7.07%-32.47%
PAVmed Inc. stock logo
PAVM
PAVmed
0.00%+7.32%+8.98%-3.12%-62.55%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FOCL
FocalTherics
2.40
Hold$7.7586.75% Upside
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
2.60
Moderate Buy$7.00115.38% Upside
Owlet, Inc. stock logo
OWLT
Owlet
2.40
Hold$15.00200.00% Upside
PAVmed Inc. stock logo
PAVM
PAVmed
2.00
Hold$56.00960.61% Upside

Current Analyst Ratings Breakdown

Latest PAVM, FOCL, KRMD, and OWLT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
FOCL
FocalTherics
Reiterated RatingBuy$10.00
8/19/2026
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
DowngradeSell (D-)Sell (E+)
8/17/2026
FOCL
FocalTherics
Reiterated RatingSell (D-)
8/14/2026
PAVmed Inc. stock logo
PAVM
PAVmed
DowngradeSell (D)Sell (E+)
8/14/2026
FOCL
FocalTherics
Reiterated RatingNeutral$4.00
8/13/2026
Owlet, Inc. stock logo
OWLT
Owlet
UpgradeSell (E+)Sell (D-)
8/6/2026
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
Reiterated RatingBuy$6.00
7/31/2026
Owlet, Inc. stock logo
OWLT
Owlet
Reiterated RatingSell (E+)
7/30/2026
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
UpgradeSell (E+)Sell (D-)
7/17/2026
PAVmed Inc. stock logo
PAVM
PAVmed
Reiterated RatingSell (D)
7/17/2026
FOCL
FocalTherics
Set Price TargetOutperform$15.00
(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FOCL
FocalTherics
$70.53M2.21N/AN/A($0.09) per share-46.11
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
$41.13M3.63N/AN/A$0.39 per share8.33
Owlet, Inc. stock logo
OWLT
Owlet
$105.70M1.38N/AN/A$0.79 per share6.33
PAVmed Inc. stock logo
PAVM
PAVmed
$70K603.43N/AN/A$1.93 per share2.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FOCL
FocalTherics
-$29.25M-$1.03N/AN/AN/A-56.26%-248.00%-44.69%N/A
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
-$2.64M-$0.04N/A65.00N/A-4.03%-10.63%-6.51%11/11/2026 (Estimated)
Owlet, Inc. stock logo
OWLT
Owlet
-$39.68M-$0.75N/AN/AN/A-8.61%-601.24%-15.96%11/12/2026 (Estimated)
PAVmed Inc. stock logo
PAVM
PAVmed
$400K-$16.05N/AN/AN/A-10,794.64%-126.43%-25.49%11/12/2026 (Estimated)

Latest PAVM, FOCL, KRMD, and OWLT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
FOCL
FocalTherics
-$0.20-$0.39-$0.19-$0.39N/A$13.20 million
8/11/2026Q2 2026
Owlet, Inc. stock logo
OWLT
Owlet
-$0.09-$0.05+$0.04-$0.05$31.71 million$33.87 million
8/5/2026Q2 2026
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
-$0.0180$0.01+$0.0280$0.01$11.62 million$12.05 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
FOCL
FocalTherics
N/AN/AN/AN/AN/A
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
N/AN/AN/AN/AN/A
Owlet, Inc. stock logo
OWLT
Owlet
N/AN/AN/AN/AN/A
PAVmed Inc. stock logo
PAVM
PAVmed
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FOCL
FocalTherics
1.79
1.60
1.38
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
N/A
2.72
2.09
Owlet, Inc. stock logo
OWLT
Owlet
N/A
1.64
1.35
PAVmed Inc. stock logo
PAVM
PAVmed
0.98
1.19
1.19

Institutional Ownership

CompanyInstitutional Ownership
FOCL
FocalTherics
62.74%
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
58.60%
Owlet, Inc. stock logo
OWLT
Owlet
72.60%
PAVmed Inc. stock logo
PAVM
PAVmed
19.93%

Insider Ownership

CompanyInsider Ownership
FOCL
FocalTherics
10.10%
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
18.50%
Owlet, Inc. stock logo
OWLT
Owlet
36.17%
PAVmed Inc. stock logo
PAVM
PAVmed
13.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
FOCL
FocalTherics
23037.53 million33.74 millionN/A
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
8045.93 million37.44 millionOptionable
Owlet, Inc. stock logo
OWLT
Owlet
10629.22 million18.65 millionNo Data
PAVmed Inc. stock logo
PAVM
PAVmed
908.00 million6.93 millionNo Data

Recent News About These Companies

PAVmed (PAVM) Q2 2026 Earnings Call Transcript
PAVmed Inc. Q2 2026 Earnings Call Summary
PAVmed Inc. (PAVM) Q2 2026 Earnings Call Transcript
PAVmed (PAVM) Q4 2025 Earnings Transcript
PAVmed Inc. (PAVM) Q1 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

FocalTherics NASDAQ:FOCL

$4.15 -0.02 (-0.48%)
As of 09/4/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

KORU Medical Systems stock logo

KORU Medical Systems NASDAQ:KRMD

$3.25 +0.03 (+0.93%)
As of 09/4/2026 04:00 PM Eastern

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Owlet stock logo

Owlet NYSE:OWLT

$5.00 -0.03 (-0.60%)
As of 09/4/2026 03:58 PM Eastern

Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.

PAVmed stock logo

PAVmed NASDAQ:PAVM

$5.34 +0.25 (+4.99%)
As of 09/4/2026 03:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.